INCOME STATEMENT
Jagsonpal Pharmaceuticals Ltd.
BSE
Apr 30
225.20
-2.10 ( -0.92%)
Volume
21692
Prev. Close
227.30
Open Price
230.80
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Apr 30
224.96
-2.50 ( -1.10%)
Volume
153359
Prev. Close
227.46
Open Price
226.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE048B01035
|
Market Cap. ( ₹ in Cr. )
|
1494.60
|
P/BV
|
7.58
|
Book Value ( ₹ )
|
29.67
|
|
BSE Code
|
507789
|
52 Week High/Low ( ₹ )
|
328/110
|
FV/ML
|
2/1
|
P/E(X)
|
66.54
|
|
NSE Code
|
JAGSNPHARMEQ
|
Book Closure
|
08/01/2025
|
EPS ( ₹ )
|
3.38
|
Div Yield (%)
|
0.89
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 208.70 | 236.71 | 226.10 | 187.95 | 158.57 |
| Total Operating Revenues | 208.70 | 236.71 | 226.10 | 187.95 | 158.57 |
| | | | | | |
| Other Income | 9.28 | 5.73 | 3.34 | 4.39 | 2.53 |
| Total Revenue | 217.98 | 242.45 | 229.43 | 192.34 | 161.09 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 22.10 | 31.21 | 40.42 | 38.63 | 36.78 |
| Purchase Of Stock-In Trade | 53.98 | 57.59 | 49.75 | 36.86 | 18.15 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 3.90 | 4.30 | 5.61 | 5.28 | 1.25 |
| Employee Benefit Expenses | 48.49 | 56.42 | 57.68 | 53.98 | 50.37 |
| Finance Costs | 0.81 | 0.41 | 0.29 | 1.09 | 0.51 |
| Provisions And Contingencies | 0.77 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation And Amortisation Expenses | 1.66 | 1.21 | 1.53 | 0.51 | 1.13 |
| Other Expenses | 56.40 | 53.04 | 46.84 | 34.11 | 43.47 |
| Total Expenses | 188.11 | 204.18 | 202.11 | 170.47 | 151.68 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 29.87 | 38.27 | 27.32 | 21.87 | 9.41 |
| | | | | | |
| Exceptional Items | 0.00 | -3.46 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 29.87 | 34.81 | 27.32 | 21.87 | 9.41 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 7.56 | 7.63 | 7.40 | 6.05 | 1.57 |
| Deferred Tax | -0.15 | 0.46 | 0.33 | -1.23 | -0.03 |
| Total Tax Expenses | 7.41 | 8.09 | 7.73 | 4.81 | 1.54 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 22.46 | 26.72 | 19.59 | 17.06 | 7.87 |
| | | | | | |
| Profit/Loss From Continuing Operations | 22.46 | 26.72 | 19.59 | 17.06 | 7.87 |
| | | | | | |
| Profit/Loss For The Period | 22.46 | 26.72 | 19.59 | 17.06 | 7.87 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 8.49 | 10.20 | 7.48 | 6.51 | 3.00 |
| Diluted EPS (Rs.) | 8.46 | 10.20 | 7.48 | 6.51 | 3.00 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 13.10 | 0.00 | 10.48 | 2.62 | 1.31 |
| Equity Dividend Rate (%) | 100.00 | 100.00 | 80.00 | 20.00 | 10.00 |